Metastatic Embryonal Conjunctival Rhabdomyosarcoma in a 4-Year-Old Boy

Almila Sarigül Sezenöz1, Aylin Karalezli, Yonca Özkan Arat

  • 1*Department of Ophthalmology, Başkent University, Ankara, Turkey; †Department of Ophthalmology, Muğla Sitki Koçman University, Muğla, Turkey; ‡Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, U.S.A.; §Department of Radiology, Başkent University, Konya, Turkey; ‖Department of Ophthalmology, Hacettepe University, Ankara, Turkey; and ¶Department of Pathology, Başkent University, Ankara, Turkey.

Insights

A rare case of embryonal rhabdomyosarcoma in a child presented as a conjunctival mass. This pediatric cancer diagnosis requires prompt histopathology and systemic evaluation for effective treatment.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Pathology

Background:

  • Conjunctival masses in children are uncommon, necessitating a broad differential diagnosis.
  • Early detection and accurate diagnosis are crucial for managing pediatric ocular tumors.

Observation:

  • A 4-year-old boy presented with a rapidly enlarging, salmon-colored mass on the left upper eyelid's palpebral conjunctiva.
  • Initial MRI showed no orbital invasion, but biopsy confirmed embryonal rhabdomyosarcoma.
  • Staging revealed metastatic disease (Stage 4) with lung nodules.

Findings:

  • The case highlights a rare presentation of embryonal rhabdomyosarcoma primarily involving the conjunctiva with distant metastasis.
  • Histopathological confirmation is essential for diagnosing this rare pediatric malignancy.
  • The absence of orbital involvement despite metastasis is an unusual feature.

Implications:

  • Conjunctival rhabdomyosarcoma should be considered in the differential diagnosis of atypical pediatric conjunctival lesions.
  • Comprehensive systemic evaluation and vigilant follow-up are mandatory for affected children.
  • Multimodal treatment including chemotherapy and radiation therapy is indicated for advanced disease.